SCHEMBL19437381

SCHEMBL19437381

CCOC(=O)c1cc(C(=O)NC)c2oc(C)c(-c3cccc(OCCO)c3)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ LMNA P02545 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ BRD4 O60885 2/20 0.36
▸ BRD2 P25440 2/20 0.36
▸ CREBBP Q92793 2/20 0.36
▸ ADORA1 P30542 1/20 0.35
▸ TP53 P04637 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28933660 0.90 NR1H4 (0.39) LMNAKMT2AALDH1A1KDM4EGAA
SCHEMBL19437263 0.89 JAK2 (0.46) L3MBTL1MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL21649772 0.87 LMNA (0.39) LMNAPOLBALDH1A1KDM4EGAA
SCHEMBL28692716 0.79 NR1H4 (0.47) MEN1KMT2ASMN1; SMN2TSHRNR1H2
SCHEMBL19456268 0.77 BRD4 (0.46) BRD4BRD2CREBBP
SCHEMBL21649780 0.77 BRD4 (0.46) BRD4BRD2CREBBP
SCHEMBL20983354 0.76 LMNA (0.37) LMNAPOLBALDH1A1KDM4EGAA
SCHEMBL19437420 0.74 KMT2A (0.41) LMNAMEN1KMT2AALDH1A1KDM4E
SCHEMBL20876256 0.72 MEN1 (0.41) L3MBTL1LMNAMEN1KMT2APOLB
SCHEMBL19437561 0.71 BRD4 (0.57) L3MBTL1TDP1BRD4BRD2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108884083-B Benzo [ B ] furans as bromodomain inhibitors 葛兰素史克知识产权第二有限公司 2022-02-25 — — CN disclosed
US-10583112-B2 Benzo[b]furans as bromodomain inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2020-03-10 — — US disclosed
EP-3440075-B1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2020-01-29 — — EP disclosed
EP-3440075-B1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE IP NO 2 LTD (GB) 2020-01-29 — — EP disclosed
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2019-05-23 — — US disclosed
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO. 2) LIMITED (GB) 2019-05-23 — — US disclosed
EP-3440075-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GlaxoSmithKline Intellectual Property (No. 2) Limited (GB) 2019-02-13 — — EP disclosed
WO-2017174620-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-10-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10583112-B2 Benzo[b]furans as bromodomain inhibitors BRD4, BRD3, BRD2 L3MBTL1 4361/4885TDP1 1483/4885LMNA 1875/4885
US-20190151279-A1 BENZO[B]FURANS AS BROMODOMAIN INHIBITORS BRD4, BRD3, BRD2 L3MBTL1 4361/4885TDP1 1483/4885LMNA 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback